那么,Monopar Therapeutics 过去12个月的利润。他们亏了2100万。所以,你往下看,每股收益是负2.41,内部人持股9.5。还不错。他们在大把大把地亏钱。过去五天、过去60天、过去一年,你们能看到,有过一次拉升,但全都还回去了。
这就是它评级不好的原因。就是负的。他们就是没在赚钱。未知。增长、利润。现金流为负。股本数量增加了42%。哎哟。
So, Monopar Therapeutics profit over the last 12 months. They lost 21 mil. So, as you go through this, earnings per share negative 2.41, held by insiders 9.5. Not bad. Um, they're losing money hand over fist.
Uh, last five days, last 60 days, last year, you guys can see had one pop, but it gave it all back. Uh, here's your This is why it's not a good grade. Just negative. They're just not making the money.
Uh, not available. Growth F profits. Cash negative. Share count went up 42%. Ouch.